We found that mPS_colon could stratify the prognosis of CRC patients with either MMR-deficient (dMMR) (Fig. 2e) or MMR-proficient (pMMR) (Supplementary Fig. 2a) tumors. Here, MRC1 is linked to colorectal carcinoma.